Identification of an Activating Mutation in the Extracellular Domain of HER2 Conferring Resistance to Pertuzumab
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s232912
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2019
Authors
Publisher
Informa UK Limited